Total Voting Rights

EnSilica

30/04/2026 17:30

RNS Number : 6785C

EnSilica PLC

30 April 2026

 

30 April 2026

 

 

EnSilica plc

("EnSilica", the "Company" or the "Group")

 

Total Voting Rights

 

EnSilica plc (AIM: ENSI), a leading fabless, micro chipmaker with a growing portfolio of reusable IP, serving the Space & Comms, Industrial, Automotive and Healthcare markets, announces that the issued share capital of the Company as at the date of this announcement comprises 117,877,230 ordinary shares of 0.1 pence each with one voting right per share ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 117,877,230.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of the Company under the Disclosure Guidance and Transparency Rules of the UK Financial Conduct Authority.

 

For further information please contact:

 

EnSilica plc
Ian Lankshear, Chief Executive Officer
Kristoff Rademan, Chief Financial Officer
www.ensilica.com
via Novella Communications
+44 (0)20 3151 7008
Allenby Capital Limited (Nominated Adviser & Joint Broker)
Jeremy Porter / Vivek Bhardwaj (Corporate Finance)
Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking)
+44 (0)20 3328 5656
info@allenbycapital.com
Panmure Liberum Limited (Joint Broker)
Edward Mansfield / Will King / Phoebe Bunce
+44 (0)20 3100 2000
Novella Communications (Investor & Financial Public Relations)
Tim Robertson / Aeliya Bilgrami
+44 (0)20 3151 7008
ensilica@novella-comms.com

 

About EnSilica plc

EnSilica is a fabless, application-specific chipmaker, combining deep domain and system-level expertise with world-class capability in RF, mmWave, mixed-signal and complex digital IC design. The Company serves customers across the space and communications, industrial, automotive and healthcare markets, where safety and security and reliability are critical.

 

A growing portfolio of reusable IP and silicon platforms underpins a repeatable, scalable delivery model, reducing development risk, cost and time to market while supporting long-term supply revenues. EnSilica has a strong track record of delivering production-proven silicon to demanding industry standards. Headquartered near Oxford, UK, the Company operates design centres across the UK, India, Brazil and Hungary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
TVRURUNRNOUSOAR